Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 11.75
-0.75 (-6.00%)
Apr 29, 2026, 5:07 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 64.94 million as of April 29, 2026. Its market cap has increased by 58.40% in one year.
Market Cap
64.94M
Enterprise Value
62.26M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.75
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 64.94M, a decrease of -42.46%. That is a compound annual growth rate of -11.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 64.94M | 67.08% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4basebio | 78.16M |
| Faron Pharmaceuticals Oy | 81.80M |
| hVIVO | 49.47M |
| Bioventix | 86.21M |
| Hemogenyx Pharmaceuticals | 44.34M |
| Poolbeg Pharma | 30.32M |
| Scancell Holdings | 142.69M |
| Sareum Holdings | 28.99M |